Cargando…
Mechanism of heart failure after myocardial infarction
Despite the widespread use of early revascularization and drugs to regulate the neuroendocrine system, the impact of such measures on alleviating the development of heart failure (HF) after myocardial infarction (MI) remains limited. Therefore, it is important to discuss the development of new thera...
Autores principales: | Jiang, Huaiyu, Fang, Tingting, Cheng, Zeyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566288/ https://www.ncbi.nlm.nih.gov/pubmed/37818767 http://dx.doi.org/10.1177/03000605231202573 |
Ejemplares similares
-
Heart failure after myocardial infarction: incidence and predictors
por: Jenča, Dominik, et al.
Publicado: (2020) -
The Biomarkers for Acute Myocardial Infarction and Heart Failure
por: Wang, Xi-Ying, et al.
Publicado: (2020) -
Macrophage Activities in Myocardial Infarction and Heart Failure
por: Duncan, Sophia Esi, et al.
Publicado: (2020) -
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
por: Bissessor, Naylin, et al.
Publicado: (2007) -
Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
por: Panahi, Mona, et al.
Publicado: (2018)